Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients

Janice Manjuck, Dhanonjoy C. Saha, Mark Astiz, Lesley Jane Eales, Eric C. Rackow

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Anti-inflammatory substances are released during septic shock that modulate monocyte function. Decreased monocyte responsiveness to bacterial toxins and decreased expression of human-leukocyte-associated antigen-DR (HLA-DR) have been reported during septic shock and critical illness. Impaired antigen presentation has been Inferred from these observations but has not been demonstrated. We assessed antigen presentation and costimulatory molecule expression in 12 age-matched control subjects, 10 noninfected critically ill patients (CINS), and 17 critically ill patients with sepsis (CIS). Antigen presentation was assessed by using in vitro lymphocyte 5-bromo-2-deoxyuridine (BrdU) incorporation in response to tetanus toxoid. The expression of HLA-DR and the costimulatory molecules CD28, CD86, and CTLA-4 was assessed by flow cytometry. Serum interleukin-10 (IL-10) was also measured by enzyme-linked immunosorbent assay. Serum IL-10 levels were significantly elevated in CIS patients (91 ± 38 pg/mL) as compared with levels in control subjects (5 ± 4 pg/mL)(P <.05). Lymphocyte BrdU incorporation increased by 710% ± 243% in control subjects but by only 144% ± 62% in CIS patients and 76% ± 31% in CINS patients (P <.01 vs control). Monocyte HLA-DR expression, monocyte CD86 expression, and lymphocyte CD28 expression were significantly decreased in CIS patients (P <.01) as compared with control subjects. Conversely, lymphocyte CTLA-4 expression was significantly increased in CIS patients (P <.05 vs control). Monocyte CD86 expression was also significantly decreased in CINS patients as compared with control subjects. These data indicate that antigen presentation is decreased in critically ill patients with sepsis. This appears in part related to decreased expression of HLA-DR and the costimulatory molecules CD86 and CD28. Increased expression of the negative signal receptor CTLA-4 may also impair antigen presentation in patients with sepsis.

Original languageEnglish (US)
Pages (from-to)153-160
Number of pages8
JournalJournal of Laboratory and Clinical Medicine
Volume135
Issue number2
StatePublished - Feb 2000
Externally publishedYes

Fingerprint

Critical Illness
Antigens
Lymphocytes
Antigen Presentation
Monocytes
HLA Antigens
Bromodeoxyuridine
Interleukin-10
Sepsis
Molecules
Septic Shock
Bacterial Toxins
Immunosorbents
Tetanus Toxoid
Flow cytometry
Assays
Anti-Inflammatory Agents
Serum
Flow Cytometry
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. / Manjuck, Janice; Saha, Dhanonjoy C.; Astiz, Mark; Eales, Lesley Jane; Rackow, Eric C.

In: Journal of Laboratory and Clinical Medicine, Vol. 135, No. 2, 02.2000, p. 153-160.

Research output: Contribution to journalArticle

@article{a87c8e6b3f764d559091ebe2ef9404b1,
title = "Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients",
abstract = "Anti-inflammatory substances are released during septic shock that modulate monocyte function. Decreased monocyte responsiveness to bacterial toxins and decreased expression of human-leukocyte-associated antigen-DR (HLA-DR) have been reported during septic shock and critical illness. Impaired antigen presentation has been Inferred from these observations but has not been demonstrated. We assessed antigen presentation and costimulatory molecule expression in 12 age-matched control subjects, 10 noninfected critically ill patients (CINS), and 17 critically ill patients with sepsis (CIS). Antigen presentation was assessed by using in vitro lymphocyte 5-bromo-2-deoxyuridine (BrdU) incorporation in response to tetanus toxoid. The expression of HLA-DR and the costimulatory molecules CD28, CD86, and CTLA-4 was assessed by flow cytometry. Serum interleukin-10 (IL-10) was also measured by enzyme-linked immunosorbent assay. Serum IL-10 levels were significantly elevated in CIS patients (91 ± 38 pg/mL) as compared with levels in control subjects (5 ± 4 pg/mL)(P <.05). Lymphocyte BrdU incorporation increased by 710{\%} ± 243{\%} in control subjects but by only 144{\%} ± 62{\%} in CIS patients and 76{\%} ± 31{\%} in CINS patients (P <.01 vs control). Monocyte HLA-DR expression, monocyte CD86 expression, and lymphocyte CD28 expression were significantly decreased in CIS patients (P <.01) as compared with control subjects. Conversely, lymphocyte CTLA-4 expression was significantly increased in CIS patients (P <.05 vs control). Monocyte CD86 expression was also significantly decreased in CINS patients as compared with control subjects. These data indicate that antigen presentation is decreased in critically ill patients with sepsis. This appears in part related to decreased expression of HLA-DR and the costimulatory molecules CD86 and CD28. Increased expression of the negative signal receptor CTLA-4 may also impair antigen presentation in patients with sepsis.",
author = "Janice Manjuck and Saha, {Dhanonjoy C.} and Mark Astiz and Eales, {Lesley Jane} and Rackow, {Eric C.}",
year = "2000",
month = "2",
language = "English (US)",
volume = "135",
pages = "153--160",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients

AU - Manjuck, Janice

AU - Saha, Dhanonjoy C.

AU - Astiz, Mark

AU - Eales, Lesley Jane

AU - Rackow, Eric C.

PY - 2000/2

Y1 - 2000/2

N2 - Anti-inflammatory substances are released during septic shock that modulate monocyte function. Decreased monocyte responsiveness to bacterial toxins and decreased expression of human-leukocyte-associated antigen-DR (HLA-DR) have been reported during septic shock and critical illness. Impaired antigen presentation has been Inferred from these observations but has not been demonstrated. We assessed antigen presentation and costimulatory molecule expression in 12 age-matched control subjects, 10 noninfected critically ill patients (CINS), and 17 critically ill patients with sepsis (CIS). Antigen presentation was assessed by using in vitro lymphocyte 5-bromo-2-deoxyuridine (BrdU) incorporation in response to tetanus toxoid. The expression of HLA-DR and the costimulatory molecules CD28, CD86, and CTLA-4 was assessed by flow cytometry. Serum interleukin-10 (IL-10) was also measured by enzyme-linked immunosorbent assay. Serum IL-10 levels were significantly elevated in CIS patients (91 ± 38 pg/mL) as compared with levels in control subjects (5 ± 4 pg/mL)(P <.05). Lymphocyte BrdU incorporation increased by 710% ± 243% in control subjects but by only 144% ± 62% in CIS patients and 76% ± 31% in CINS patients (P <.01 vs control). Monocyte HLA-DR expression, monocyte CD86 expression, and lymphocyte CD28 expression were significantly decreased in CIS patients (P <.01) as compared with control subjects. Conversely, lymphocyte CTLA-4 expression was significantly increased in CIS patients (P <.05 vs control). Monocyte CD86 expression was also significantly decreased in CINS patients as compared with control subjects. These data indicate that antigen presentation is decreased in critically ill patients with sepsis. This appears in part related to decreased expression of HLA-DR and the costimulatory molecules CD86 and CD28. Increased expression of the negative signal receptor CTLA-4 may also impair antigen presentation in patients with sepsis.

AB - Anti-inflammatory substances are released during septic shock that modulate monocyte function. Decreased monocyte responsiveness to bacterial toxins and decreased expression of human-leukocyte-associated antigen-DR (HLA-DR) have been reported during septic shock and critical illness. Impaired antigen presentation has been Inferred from these observations but has not been demonstrated. We assessed antigen presentation and costimulatory molecule expression in 12 age-matched control subjects, 10 noninfected critically ill patients (CINS), and 17 critically ill patients with sepsis (CIS). Antigen presentation was assessed by using in vitro lymphocyte 5-bromo-2-deoxyuridine (BrdU) incorporation in response to tetanus toxoid. The expression of HLA-DR and the costimulatory molecules CD28, CD86, and CTLA-4 was assessed by flow cytometry. Serum interleukin-10 (IL-10) was also measured by enzyme-linked immunosorbent assay. Serum IL-10 levels were significantly elevated in CIS patients (91 ± 38 pg/mL) as compared with levels in control subjects (5 ± 4 pg/mL)(P <.05). Lymphocyte BrdU incorporation increased by 710% ± 243% in control subjects but by only 144% ± 62% in CIS patients and 76% ± 31% in CINS patients (P <.01 vs control). Monocyte HLA-DR expression, monocyte CD86 expression, and lymphocyte CD28 expression were significantly decreased in CIS patients (P <.01) as compared with control subjects. Conversely, lymphocyte CTLA-4 expression was significantly increased in CIS patients (P <.05 vs control). Monocyte CD86 expression was also significantly decreased in CINS patients as compared with control subjects. These data indicate that antigen presentation is decreased in critically ill patients with sepsis. This appears in part related to decreased expression of HLA-DR and the costimulatory molecules CD86 and CD28. Increased expression of the negative signal receptor CTLA-4 may also impair antigen presentation in patients with sepsis.

UR - http://www.scopus.com/inward/record.url?scp=0034141377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034141377&partnerID=8YFLogxK

M3 - Article

VL - 135

SP - 153

EP - 160

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 2

ER -